Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Cytokinetics Inc

+ Add to Watchlist

CYTK:US

7.7100 USD 0.2500 3.14%

As of 20:10:00 ET on 02/27/2015.

Snapshot for Cytokinetics Inc (CYTK)

Open: 8.0500 Day's Range: 7.6800 - 8.0700 Volume: 379,806
Previous Close: 7.9600 52wk Range: 3.0500 - 13.2600 1-Yr Rtn: -21.73%

Stock Chart for CYTK

No chart data available.
  • CYTK:US 7.7100
  • 1D
  • 1M
  • 1Y
7.9600
Interactive CYTK Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CYTK

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.4300
Est. EPS (USD) (12/2015) -0.6100
Est. PEG Ratio -
Market Cap (M USD) 282.25
Shares Outstanding (M) 36.61
30 Day Average Volume 478,140
Price/Book (mrq) 3.0659
Price/Sale (ttm) 5.9087
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/06/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CYTK

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CYTK

Cytokinetics, Incorporated is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions.

Robert I BlumPresident/CEOSharon A Barbari "Surrey"Exec VP:Finance/CFO/Secretary
Fady I MalikSenior VP:Research & Early DevAndrew A WolffSenior VP:Clinical Research
More Company Profile & Key Executives for CYTK

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil